Details

MIPS - Quality Measures - Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet

Quality Measures
Category QUALITY
Description Percentage of patients 18 years of age and older who were diagnosed with acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease (IVD) during the measurement period, and who had documentation of use of aspirin or another antiplatelet during the measurement period.
eMeasure ID CMS164v5
First Performance Year 2017
Last Performance Year
Metric Type Single Performance Rate
National Quality Strategy Domain ECC
Measure Type Process
eMeasure UUID 40280381-52fc-3a32-0153-5736a9401b9f
NQF eMeasure ID
NQF ID 0068
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward National Committee for Quality Assurance
Submission Methods Claims | Electronic Health Record | Cms Web Interface | Registry
Eligibility Options
Performance Options
Is Risk Adjusted?
Vendor ID
Is Registry Measure?
Registry Measure Spec https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_204_Registry.pdf
Web Interface Measure Spec https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Web-Interface-Measures/2017 WI_IVD2.pdf
Claims Measure Spec https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_204_Claims.pdf

Back to List